Log in

Liquidia Technologies Stock Price, Forecast & Analysis (NASDAQ:LQDA)

$3.61
+0.07 (+1.98 %)
(As of 11/16/2019 08:00 AM ET)
Today's Range
$3.61
Now: $3.61
$3.77
50-Day Range
$3.39
MA: $4.13
$5.18
52-Week Range
$3.25
Now: $3.61
$27.44
Volume79,400 shs
Average Volume30,456 shs
Market Capitalization$67.29 million
P/E RatioN/A
Dividend YieldN/A
Beta0.54
Liquidia Technologies, Inc, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of human therapeutics. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials used for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LQDA
CUSIPN/A
CIKN/A
Phone919-328-4400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.71 million
Book Value$1.05 per share

Profitability

Net Income$-53,140,000.00

Miscellaneous

EmployeesN/A
Market Cap$67.29 million
Next Earnings Date2/25/2020 (Estimated)
OptionableNot Optionable

Receive LQDA News and Ratings via Email

Sign-up to receive the latest news and ratings for LQDA and its competitors with MarketBeat's FREE daily newsletter.


Liquidia Technologies (NASDAQ:LQDA) Frequently Asked Questions

What is Liquidia Technologies' stock symbol?

Liquidia Technologies trades on the NASDAQ under the ticker symbol "LQDA."

How were Liquidia Technologies' earnings last quarter?

Liquidia Technologies Inc (NASDAQ:LQDA) issued its quarterly earnings data on Wednesday, November, 13th. The company reported ($0.72) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.52) by $0.20. View Liquidia Technologies' Earnings History.

When is Liquidia Technologies' next earnings date?

Liquidia Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Liquidia Technologies.

What price target have analysts set for LQDA?

1 brokers have issued 12-month price targets for Liquidia Technologies' shares. Their forecasts range from $50.00 to $50.00. On average, they anticipate Liquidia Technologies' stock price to reach $50.00 in the next twelve months. This suggests a possible upside of 1,285.0% from the stock's current price. View Analyst Price Targets for Liquidia Technologies.

What is the consensus analysts' recommendation for Liquidia Technologies?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Liquidia Technologies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Liquidia Technologies.

What are Wall Street analysts saying about Liquidia Technologies stock?

Here are some recent quotes from research analysts about Liquidia Technologies stock:
  • 1. According to Zacks Investment Research, "Liquidia Technologies, Inc. is a late-stage clinical biopharmaceutical company. It focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. The company's product candidate consists of LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain which are in clinical stage. Liquidia Technologies, Inc. is based in NC, United States. " (10/9/2019)
  • 2. Wedbush analysts commented, "We base our $27 price target on a sum-of-the-parts analysis derived from: (1) the P/E value of La Jolla’s current commercial business (Giapreza); (2) an NPV of its pipeline (LJPC-401); and (3) our estimated year-end 2019 fully diluted net cash of $2.03/share to arrive at our price target. We value the current commercial business at $12.94 per share and the pipeline at $11.99 per share. The commercial business value is based on a P/E multiple assumption of 30x our 2024E EPS of $0.75, discounted at 15%." (6/28/2019)

Has Liquidia Technologies been receiving favorable news coverage?

News articles about LQDA stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Liquidia Technologies earned a daily sentiment score of -3.5 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for Liquidia Technologies.

Are investors shorting Liquidia Technologies?

Liquidia Technologies saw a decline in short interest in the month of October. As of October 31st, there was short interest totalling 338,600 shares, a decline of 19.6% from the September 30th total of 421,000 shares. Based on an average trading volume of 62,900 shares, the short-interest ratio is currently 5.4 days. Approximately 4.9% of the shares of the stock are sold short. View Liquidia Technologies' Current Options Chain.

Who are some of Liquidia Technologies' key competitors?

What other stocks do shareholders of Liquidia Technologies own?

Who are Liquidia Technologies' key executives?

Liquidia Technologies' management team includes the folowing people:
  • Mr. Neal F. Fowler, CEO & Director (Age 57)
  • Mr. Robert A. Lippe, Chief Operations Officer (Age 54)
  • Mr. William R. Kenan Jr., Co-Founder
  • Dr. Ginger Denison, Co-Founder
  • Mr. Timothy M. Albury, Interim Chief Financial Officer (Age 50)

When did Liquidia Technologies IPO?

(LQDA) raised $50 million in an initial public offering on Thursday, July 26th 2018. The company issued 4,500,000 shares at a price of $10.00-$12.00 per share. Jefferies and Cowen served as the underwriters for the IPO and Needham & Company and Wedbush PacGrow were co-managers.

How do I buy shares of Liquidia Technologies?

Shares of LQDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Liquidia Technologies' stock price today?

One share of LQDA stock can currently be purchased for approximately $3.61.

How big of a company is Liquidia Technologies?

Liquidia Technologies has a market capitalization of $67.29 million and generates $2.71 million in revenue each year. The company earns $-53,140,000.00 in net income (profit) each year or ($7.51) on an earnings per share basis. View Additional Information About Liquidia Technologies.

What is Liquidia Technologies' official website?

The official website for Liquidia Technologies is http://www.liquidia.com/.

How can I contact Liquidia Technologies?

Liquidia Technologies' mailing address is 419 DAVIS DRIVE SUITE 100, MORRISVILLE NC, 27560. The company can be reached via phone at 919-328-4400 or via email at [email protected]


MarketBeat Community Rating for Liquidia Technologies (NASDAQ LQDA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  103 (Vote Outperform)
Underperform Votes:  117 (Vote Underperform)
Total Votes:  220
MarketBeat's community ratings are surveys of what our community members think about Liquidia Technologies and other stocks. Vote "Outperform" if you believe LQDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LQDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel